2016年第二届国际病毒性肿瘤暨新药研发高峰论坛_门票优惠

September 16
Time	Content	Speaker
8:30-9:00	大会开幕致欢迎词	庄辉院士、管委会领导、陈洪主任
9:00-9:30	Structural basis of enveloped virus entry and fusion	Prof. George F. Gao （ Academician,中国科学院院士 Institute of Microbiology, CAS & Deputy-Director of China CDC）
Session I : DNA Tumor viruses and Cancer Therapy Chairs： Prof. Ke Lan & Prof. Grant McFadden
9:30-10:00	Identification of new human Polyomaviruses and their use as model agents for cancer cell studies	Prof. Patrick Moors (NAS members,美国科学院院士 University of Pittsburg )
10:00-10;30	Exploiting Oncolytic Virotherapy to Treat Cancer	Prof. Grant McFadden （University of Florida, Editor-in-Chief of PLoS Pathogens ）
10:30-10:45	Coffee break
10:45-11:15	HPV and DNA Damage Response	Prof. Laimonis A. Laimins （Chair of Department of Microbiology, Northwest University）
11:15-11:45	Mechanism of KSHV Latency and cellular transformation	Prof. Shou-jiang Gao University of Southern California
11:45-12:00	Towards better understanding of KSHV latency and oncogenesis	Prof. Ke Lan Pasteur Institute of Shanghai
12:00-13:30	Lunch
Session II ： Hepatitis Viruses and Liver Cancer Chairs ：Prof.Hui Zhuang & Dr.Rajen Koshy
13:30-14:00	New insights into inflammation regulation and Liver Cancer	Prof. Hong-yang Wang (Academician,中国工程院院士), The 2nd Military Medical University of Shanghai）
14:00-14:30	Mechanism of hepatitis B virus persistence in the offspring after Vertical transmission	Prof. James Ou （University of Southern California , Editor of Journal of Virology）
14:30-15:00	Hepatitis B virus Capsid Stability, Persistence, Host Tropism and immune Response	Prof. Jian-ming Hu Pennsylvania State University
15:00-15:20	Interconnections between the enzymology of the HBV RNase and Drug discovery	Prof. John Tavis Saint Louise University
15:20-15;45	Coffee break
15:45-15:30	Short talks chosen from abstracts
17:30- 18:00	Introduction of a special Sponsor

September 17
Time	Content	Speaker
Session III :Hepatitis B Virus and liver Cancer Chairs：Prof. Jiang-guo Wu & Prof. Aleem Siddiqui
8;30-9:00	Mitochondrial dynamics and Innate immunity in chronic hepatitis B	Prof. Aleem Siddiqui University of California San Diego
9:00-9:30	Hepatitis Virus Infection and Host Innate Immunity	Prof. Jiang-guo Wu Wuhan University，Director of National Key Lab in Virology
9:30-10:00	Is there a RNA genome form HBV virion and its potential clinical significance	Prof. Feng-min Lu Peking University Health Science Center
10:00-10:15	Introduction of a special Sponsor
10:15-10:30	Coffee break
10:30-12:00	Round table: Research Corporation between USA and China Chairs: Drs. Rajen Koshy, Hui Zhang, Jim Ou and Xin-wen Chen
12:00-13:30	Lunch
Session IV ：Hepatitis C Viruses and Liver Cancer Chairs ：Prof. Xin-wen Chen & Prof. Peter Sarnow
13:30-14:00	Virus host interactions in hepatitis C virus-infected cells	Prof. Peter Sarnow，Chair of Department of Microbiology, Stanford University, Editor of Virology
14:00-14:30	Imaging hepatitis C virus entry into polarized hepatocyte organoids	Glenn Randall Department of Microbiology The University of Chicago
14:30-15:00	The Key immune impairment that leads to persistent Hepatitis C virus Infection	Prof. Hong Tang Director of Pasteur Institute of Shanghai
15:00-15:30	Hepatitis C virus and metabolic syndrome	Prof. Xin-wen Chen Director of Wuhan Institute of Virology, CAS
15:30-15:45	Coffee break
15:45-16:30	Short talks chosen from abstracts
16:30- 18;00	Poster session(Coffee，tea and wine)

September18
Time	Content	Speaker
Session V：Antiviral drug discovery and cancer therapy Chairs：Jim wu（founder and CEO ,Ark Biosciences Inc.）and Prof.Devin E .Eckhoff
8:30-9:00	Xenotransplantation : The Future is closer than you think	Prof . Devin E. Eckhoff Director of Transplant Institute University of Alabama at Birmingham
9:00-9:30	Protein Drug Discovery in Vivo	Prof .De-xi Liu Chair, Department of Pharmaceutical & Biomedical Sciences, University of Georgia
9:30-9:50	Update on novel approaches to discover the next generation anti-HBV drugs	Dr. Bao-hua Gu Senior Scientist, Novartis
9:50-10:05	Coffee break
10:05-10:25	Virus-derived Drugs and Transplant Rejection ：Searching for the Sweet Spot	Dr. Alexandra Lucas University of Florida
10:25-10:45	HBV cccDNA kinetics and viral integration in long-term HBV infection model in primary human hepatocytes	Dr. Guo-feng Chen Senior Scientist, Gilead Science
10:45-11:05	“IMLYGIC”(Talimogene Laherparepvec) Overview	Dr.Jacqueline Huang Medical Development, Amgen China
11:05-11:45	Short talks chosen from abstracts
11:45-12:00	Introduction of A Special Sponsor
12:00-13:30	Lunch
13:30-16:30	Mini trip
16:30	Departure

Grant McFadden

University of Florida

Editor

Devin E. Eckhoff

Devin E. Eckhoff, M.D

Professor of Surgery

Patrick Moore

US National Academy of Sciences

Member

王红阳

上海东方肝胆外科研究所

副所长

高福

中国科学院

院士

罗光湘

北京大学医

特聘教授

im Wu

board of Ark Biosciences

CEO

ames Jing-Hsiung Ou

University of Southern California

Professor

庄辉

中国北京大学基础医学院

中国工程院院士

南京生物医药谷会展中心

参会注册	汇款时间	RMB
	及早注册（before8/15）	2680元
	标准会费(8/15-9/16)	3580元

注：
1. （包含参会费、9.16-9.18的午餐各一顿、9.16-9.17的晚餐各一顿、茶歇数次、18日下午参观游玩活动）差旅交通、住宿、早餐需自理

会议投稿

凡未公开发表并与本次会议议题相关的研究论文均可投稿

截止日期：
所有投稿需在2016年8月31日前完成

摘要格式：
摘要语言为英语，建议字数（包括内容及致谢）不超过500字。格式请用PDF。

投稿地址：
投稿请发邮箱： business@veryevent.com 并将您的个人信息用以下格式填好一并发送。

FristName
lastName
Email
Author Affiliations
Message
Author Affiliations
投稿文件
导师姓名
导师单位
Professor’s E-mail
投稿类型

壁报制作及展示要求：
所有投稿的会议摘要经评选委员会初步审查接收后，均参加壁报展示交流。壁报语言为英语，展示安排在会议期间进行，会议现场提供壁报展板及大头针/双面胶，壁报规格为1.5米高、0.9米宽。
壁报张贴于9月15号下午2点后开始进行，请各位壁报展示者根据提供的壁报编号在指定的展板位置进行张贴，9月18日中午12点后除下壁报。

会议标签：

肿瘤新药研发

活动家提供2016年第二届国际病毒性肿瘤暨新药研发高峰论坛官网最新门票优惠(更新于:2016年08月01日)。2016年第二届国际病毒性肿瘤暨新药研发高峰论坛将于2016年09月16日在南京召开，优惠票在线报名截止2016年09月16日。一键查询2016年第二届国际病毒性肿瘤暨新药研发高峰论坛会议通知及邀请函下载，包含开会时间地点、嘉宾演讲主题、日程、价格等会议信息，报名2016年第二届国际病毒性肿瘤暨新药研发高峰论坛，轻松快捷。

2016年第二届国际病毒性肿瘤暨新药研发高峰论坛

2025（第七届）世界细胞治疗与再生医学大会暨展览会

2024CBIIC第九届医药创新与投资大会

2016年第二届国际病毒性肿瘤暨新药研发高峰论坛

2025（第七届） 世界细胞治疗与再生医学大会暨展览会

2024CBIIC第九届医药创新与投资大会

2025（第七届）世界细胞治疗与再生医学大会暨展览会